Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.
Identifieur interne : 004109 ( Main/Curation ); précédent : 004108; suivant : 004110Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.
Auteurs : Elizabeth Webb [Australie] ; John Cox ; Stirling EdwardsSource :
- Virus genes [ 0920-8569 ] ; 2005.
Descripteurs français
- KwdFr :
- ADN viral (composition chimique), ADN viral (isolement et purification), Alignement de séquences (MeSH), Analyse de séquence d'ADN (MeSH), Biosynthèse des protéines (MeSH), Codon d'initiation (MeSH), Données de séquences moléculaires (MeSH), Femelle (MeSH), Humains (MeSH), Papillomaviridae (génétique), Papillomaviridae (isolement et purification), Papillomaviridae (métabolisme), Papillomaviridae (pathogénicité), Protéines de capside (MeSH), Protéines des oncogènes viraux (biosynthèse), Protéines des oncogènes viraux (génétique), Séquence nucléotidique (MeSH), Tumeurs du col de l'utérus (virologie), Virosomes (biosynthèse).
- MESH :
- biosynthèse : Protéines des oncogènes viraux, Virosomes.
- composition chimique : ADN viral.
- génétique : Papillomaviridae, Protéines des oncogènes viraux.
- isolement et purification : ADN viral, Papillomaviridae.
- métabolisme : Papillomaviridae.
- pathogénicité : Papillomaviridae.
- virologie : Tumeurs du col de l'utérus.
- Alignement de séquences, Analyse de séquence d'ADN, Biosynthèse des protéines, Codon d'initiation, Données de séquences moléculaires, Femelle, Humains, Protéines de capside, Séquence nucléotidique.
English descriptors
- KwdEn :
- Base Sequence (MeSH), Capsid Proteins (MeSH), Codon, Initiator (MeSH), DNA, Viral (chemistry), DNA, Viral (isolation & purification), Female (MeSH), Humans (MeSH), Molecular Sequence Data (MeSH), Oncogene Proteins, Viral (biosynthesis), Oncogene Proteins, Viral (genetics), Papillomaviridae (genetics), Papillomaviridae (isolation & purification), Papillomaviridae (metabolism), Papillomaviridae (pathogenicity), Protein Biosynthesis (MeSH), Sequence Alignment (MeSH), Sequence Analysis, DNA (MeSH), Uterine Cervical Neoplasms (virology), Virosomes (biosynthesis).
- MESH :
- chemical , biosynthesis : Oncogene Proteins, Viral, Virosomes.
- chemical , chemistry : DNA, Viral.
- chemical , genetics : Oncogene Proteins, Viral.
- chemical , isolation & purification : DNA, Viral.
- chemical : Capsid Proteins, Codon, Initiator.
- genetics : Papillomaviridae.
- isolation & purification : Papillomaviridae.
- metabolism : Papillomaviridae.
- pathogenicity : Papillomaviridae.
- virology : Uterine Cervical Neoplasms.
- Base Sequence, Female, Humans, Molecular Sequence Data, Protein Biosynthesis, Sequence Alignment, Sequence Analysis, DNA.
Abstract
All known sequences of the DNA encoding the major cervical cancer-causing human papillomavirus type 16 (HPV16) L1 capsid protein contain initiation codons which would allow translation to begin at either nucleotide 5559 or 5637. However the formation of virus-like particles (VLPs) only occurs efficiently when the initiation codon at nucleotide 5637 is used for in vitro expression studies. This knowledge, in concert with the fact that virions have not been observed in HPV16-infected epithelium, raises the notion that the major L1 translation product in this HPV type may be largely confined to initiation at nucleotide 5559. Sequence analysis of various HPV types associated with particular clinical outcomes has revealed that L1 sequences of the major cervical cancer-associated viruses generally possess the ability to encode a longer translation product whilst the non-cancer-causing viruses do not. Equally intriguing, the upstream initiation codon is always separated by 78 nucleotides from the initiation codon that produces L1 protein which efficiently assembles into VLPs. We speculate that the longer L1 protein could play a role in the development of cervical carcinoma and that HPVs with the potential to cause cervical cancer may be identified by the presence of an in-frame ATG situated 78 nucleotides upstream.
DOI: 10.1007/s11262-004-4579-8
PubMed: 15744560
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004109
Links to Exploration step
pubmed:15744560Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.</title><author><name sortKey="Webb, Elizabeth" sort="Webb, Elizabeth" uniqKey="Webb E" first="Elizabeth" last="Webb">Elizabeth Webb</name><affiliation wicri:level="1"><nlm:affiliation>CSL Limited, 45 Poplar Road, Parkville, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CSL Limited, 45 Poplar Road, Parkville, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Cox, John" sort="Cox, John" uniqKey="Cox J" first="John" last="Cox">John Cox</name></author><author><name sortKey="Edwards, Stirling" sort="Edwards, Stirling" uniqKey="Edwards S" first="Stirling" last="Edwards">Stirling Edwards</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15744560</idno><idno type="pmid">15744560</idno><idno type="doi">10.1007/s11262-004-4579-8</idno><idno type="wicri:Area/Main/Corpus">004109</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">004109</idno><idno type="wicri:Area/Main/Curation">004109</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">004109</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.</title><author><name sortKey="Webb, Elizabeth" sort="Webb, Elizabeth" uniqKey="Webb E" first="Elizabeth" last="Webb">Elizabeth Webb</name><affiliation wicri:level="1"><nlm:affiliation>CSL Limited, 45 Poplar Road, Parkville, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CSL Limited, 45 Poplar Road, Parkville, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Cox, John" sort="Cox, John" uniqKey="Cox J" first="John" last="Cox">John Cox</name></author><author><name sortKey="Edwards, Stirling" sort="Edwards, Stirling" uniqKey="Edwards S" first="Stirling" last="Edwards">Stirling Edwards</name></author></analytic><series><title level="j">Virus genes</title><idno type="ISSN">0920-8569</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Base Sequence (MeSH)</term><term>Capsid Proteins (MeSH)</term><term>Codon, Initiator (MeSH)</term><term>DNA, Viral (chemistry)</term><term>DNA, Viral (isolation & purification)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Molecular Sequence Data (MeSH)</term><term>Oncogene Proteins, Viral (biosynthesis)</term><term>Oncogene Proteins, Viral (genetics)</term><term>Papillomaviridae (genetics)</term><term>Papillomaviridae (isolation & purification)</term><term>Papillomaviridae (metabolism)</term><term>Papillomaviridae (pathogenicity)</term><term>Protein Biosynthesis (MeSH)</term><term>Sequence Alignment (MeSH)</term><term>Sequence Analysis, DNA (MeSH)</term><term>Uterine Cervical Neoplasms (virology)</term><term>Virosomes (biosynthesis)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral (composition chimique)</term><term>ADN viral (isolement et purification)</term><term>Alignement de séquences (MeSH)</term><term>Analyse de séquence d'ADN (MeSH)</term><term>Biosynthèse des protéines (MeSH)</term><term>Codon d'initiation (MeSH)</term><term>Données de séquences moléculaires (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Papillomaviridae (génétique)</term><term>Papillomaviridae (isolement et purification)</term><term>Papillomaviridae (métabolisme)</term><term>Papillomaviridae (pathogénicité)</term><term>Protéines de capside (MeSH)</term><term>Protéines des oncogènes viraux (biosynthèse)</term><term>Protéines des oncogènes viraux (génétique)</term><term>Séquence nucléotidique (MeSH)</term><term>Tumeurs du col de l'utérus (virologie)</term><term>Virosomes (biosynthèse)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Oncogene Proteins, Viral</term><term>Virosomes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Oncogene Proteins, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>DNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Capsid Proteins</term><term>Codon, Initiator</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Protéines des oncogènes viraux</term><term>Virosomes</term></keywords><keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr"><term>ADN viral</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Papillomaviridae</term><term>Protéines des oncogènes viraux</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>ADN viral</term><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Base Sequence</term><term>Female</term><term>Humans</term><term>Molecular Sequence Data</term><term>Protein Biosynthesis</term><term>Sequence Alignment</term><term>Sequence Analysis, DNA</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Alignement de séquences</term><term>Analyse de séquence d'ADN</term><term>Biosynthèse des protéines</term><term>Codon d'initiation</term><term>Données de séquences moléculaires</term><term>Femelle</term><term>Humains</term><term>Protéines de capside</term><term>Séquence nucléotidique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">All known sequences of the DNA encoding the major cervical cancer-causing human papillomavirus type 16 (HPV16) L1 capsid protein contain initiation codons which would allow translation to begin at either nucleotide 5559 or 5637. However the formation of virus-like particles (VLPs) only occurs efficiently when the initiation codon at nucleotide 5637 is used for in vitro expression studies. This knowledge, in concert with the fact that virions have not been observed in HPV16-infected epithelium, raises the notion that the major L1 translation product in this HPV type may be largely confined to initiation at nucleotide 5559. Sequence analysis of various HPV types associated with particular clinical outcomes has revealed that L1 sequences of the major cervical cancer-associated viruses generally possess the ability to encode a longer translation product whilst the non-cancer-causing viruses do not. Equally intriguing, the upstream initiation codon is always separated by 78 nucleotides from the initiation codon that produces L1 protein which efficiently assembles into VLPs. We speculate that the longer L1 protein could play a role in the development of cervical carcinoma and that HPVs with the potential to cause cervical cancer may be identified by the presence of an in-frame ATG situated 78 nucleotides upstream.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15744560</PMID><DateCompleted><Year>2005</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0920-8569</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Virus genes</Title><ISOAbbreviation>Virus Genes</ISOAbbreviation></Journal><ArticleTitle>Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.</ArticleTitle><Pagination><MedlinePgn>31-5</MedlinePgn></Pagination><Abstract><AbstractText>All known sequences of the DNA encoding the major cervical cancer-causing human papillomavirus type 16 (HPV16) L1 capsid protein contain initiation codons which would allow translation to begin at either nucleotide 5559 or 5637. However the formation of virus-like particles (VLPs) only occurs efficiently when the initiation codon at nucleotide 5637 is used for in vitro expression studies. This knowledge, in concert with the fact that virions have not been observed in HPV16-infected epithelium, raises the notion that the major L1 translation product in this HPV type may be largely confined to initiation at nucleotide 5559. Sequence analysis of various HPV types associated with particular clinical outcomes has revealed that L1 sequences of the major cervical cancer-associated viruses generally possess the ability to encode a longer translation product whilst the non-cancer-causing viruses do not. Equally intriguing, the upstream initiation codon is always separated by 78 nucleotides from the initiation codon that produces L1 protein which efficiently assembles into VLPs. We speculate that the longer L1 protein could play a role in the development of cervical carcinoma and that HPVs with the potential to cause cervical cancer may be identified by the presence of an in-frame ATG situated 78 nucleotides upstream.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CSL Limited, 45 Poplar Road, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Stirling</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virus Genes</MedlineTA><NlmUniqueID>8803967</NlmUniqueID><ISSNLinking>0920-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018387">Codon, Initiator</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C114580">HPV L1 protein, Human papillomavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009856">Oncogene Proteins, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022701">Virosomes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Virus Genes. 2006 Oct;33(2):265</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018387" MajorTopicYN="Y">Codon, Initiator</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009856" MajorTopicYN="N">Oncogene Proteins, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027383" MajorTopicYN="N">Papillomaviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022701" MajorTopicYN="N">Virosomes</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>3</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>8</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>3</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15744560</ArticleId><ArticleId IdType="doi">10.1007/s11262-004-4579-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hum Gene Ther. 2000 May 20;11(8):1165-76</Citation><ArticleIdList><ArticleId IdType="pubmed">10834618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Feb;57(2):688-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3003400</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1985 Aug;145(1):181-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2990099</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1997 Aug;65(8):3328-36</Citation><ArticleIdList><ArticleId IdType="pubmed">9234794</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1988 Jun;69 ( Pt 6):1263-73</Citation><ArticleIdList><ArticleId IdType="pubmed">2838573</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1991 Dec;72 ( Pt 12):2981-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1662690</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1990 Sep;71 ( Pt 9):2185-90</Citation><ArticleIdList><ArticleId IdType="pubmed">2170578</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1334560</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Jun;182(2):513-21</Citation><ArticleIdList><ArticleId IdType="pubmed">1850917</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Mar;181(1):419-23</Citation><ArticleIdList><ArticleId IdType="pubmed">1847266</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Nov;185(1):251-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1656586</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Feb 6;348(6):518-27</Citation><ArticleIdList><ArticleId IdType="pubmed">12571259</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Jun;58(3):991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3009902</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Nov 21;347(21):1645-51</Citation><ArticleIdList><ArticleId IdType="pubmed">12444178</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1992 Feb;186(2):770-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1310198</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Jul;171(1):306-11</Citation><ArticleIdList><ArticleId IdType="pubmed">2545036</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1989 Feb;108(2):229-41</Citation><ArticleIdList><ArticleId IdType="pubmed">2645293</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 1992 Mar;79(3):328-37</Citation><ArticleIdList><ArticleId IdType="pubmed">1310805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1993 Dec;67(12 ):6929-36</Citation><ArticleIdList><ArticleId IdType="pubmed">8230414</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1995 May;76 ( Pt 5):1141-53</Citation><ArticleIdList><ArticleId IdType="pubmed">7537325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1991 Aug;65(8):4216-25</Citation><ArticleIdList><ArticleId IdType="pubmed">1649326</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1991 Mar;181(1):203-10</Citation><ArticleIdList><ArticleId IdType="pubmed">1847256</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Soc Trans. 1994 Aug;22(3):335S</Citation><ArticleIdList><ArticleId IdType="pubmed">7821591</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1989 Nov;70 ( Pt 11):3099-104</Citation><ArticleIdList><ArticleId IdType="pubmed">2555440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004109 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004109 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:15744560
|texte= Cervical cancer-causing human papillomaviruses have an alternative initiation site for the L1 protein.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:15744560" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |